Repligen Corporation (RGEN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 166.39 |
| Open | 165.96 |
| Bid | 163.85 x 200 |
| Ask | 164.34 x 100 |
| Day's range | 160.91 - 166.21 |
| 52-week range | 110.45 - 211.13 |
| Volume | |
| Avg. volume | 538,924 |
| Market cap | 9.167B |
| Beta (5Y monthly) | 1.01 |
| PE ratio (TTM) | 224.89 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund’s Investor Class fund ARTMX returned 10.41%, Advisor Class fund APDMX posted a return of 10.40%, and Institutional Class fund APHMX returned 10.44%, compared […]
- Simply Wall St.
Are Repligen Corporation's (NASDAQ:RGEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
It is hard to get excited after looking at Repligen's (NASDAQ:RGEN) recent performance, when its stock has declined...
- GuruFocus.com
Repligen Corp CEO Anthony Hunt Sells 16,707 Shares
Repligen Corp (NASDAQ:RGEN), a bioprocessing company focused on the development, manufacture, and commercialization of products used in the process of drug manufacturing, has reported an insider sale according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.